Page 27 - 《中国药房》2024年9期
P. 27

参考文献                                               [ 9 ]  NIU G H,ZHOU M,WANG F,et al. Marein ameliorates
          [ 1 ]  张译文,李昱锦,胡冰芳,等.3种小鼠酒精性肝病短期模                       Ang Ⅱ/hypoxia-induced abnormal glucolipid metabolism
              型的评价[J]. 药学学报,2018,53(2):236-243.                   by  modulating  the  HIF-1α/PPARα/γ  pathway  in  H9c2
              ZHANG Y W,LI Y J,HU B F,et al. Evaluation on three   cells[J]. Drug Dev Res,2021,82(4):523-532.
              short-term  animal  models  of  alcoholic  liver  disease[J].   [10]  ZHANG P P,ZHUO B Y,DUAN Z W,et al. Marein re‐
              Acta Pharm Sin,2018,53(2):236-243.                  duces  lipid  levels  via  modulating  the  PI3K/AKT/mTOR
          [ 2 ]  李玥,杨松. 酒精性肝病研究进展[J/OL]. 中国肝脏病杂                   pathway to induce lipophagy[J].J Ethnopharmacol,2023,
              志(电子版),2022,14(3):1-4[2024-03-01]. https://zggz‐    312:116523.
              bzz.boyuancb.com/Magazine/Show.aspx?ID=139366.  [11]  陈瑶. 基于血清药物化学技术的两色金鸡菊活性成分分
              DOI:10.3969/j.issn.1674-7380.2022.03.001.           析及药代动力学研究[D]. 乌鲁木齐:新疆医科大学,2017.
              LI Y,YANG S. Progress on alcoholic liver disease[J/OL].   CHEN Y.  Study  on  serum  pharmacochemistry  and  phar‐
              Chin J Liver Dis Electron Version,2022,14(3):1-4[2024-  macokinetics of Coreopsis tinctoria[D].Urumqi:Xinjiang
              03-01].https://zggzbzz.boyuancb.com/Magazine/Show.aspx?  Medical University,2017.
              ID=139366.DOI:10.3969/j.issn.1674-7380.2022.03.001.  [12]  WANG F,ZHOU R J,ZHAO X,et al. Apigenin inhibits
          [ 3 ]  单朋涛,葛文静,付俊敏,等 . 核受体 PPAR、FXR、LXR                 ethanol-induced oxidative stress and LPS-induced inflam‐
              在非酒精性脂肪肝中的调节作用和靶点[J]. 生命的化                          matory cytokine production in cultured rat hepatocytes[J].
              学,2023,9(8):1237-1245.                              J Appl Biomed,2018,16(1):75-80.
              SHAN P T,GE W J,FU J M,et al. The regulation and tar‐  [13]  袁叶飞,胡祥宇,欧贤红. 赶黄草对体外诱导的酒精性脂
              get of nuclear receptors PPAR,FXR and LXR in nonalco‐  肪肝细胞的影响[J]. 泸州医学院学报,2013,36(1):35-38.
              holic fatty liver disease[J]. Chem Life,2023,9(8):1237-  YUAN Y F,HU X Y,OU X H. Effect of Penthorum chi‐
              1245.                                               nense  Pursh  on  cells  of  alcoholic  fatty  liver  induced  by
          [ 4 ]  杜延超,肖默,杨瑞,等. 急性和慢性酒精性脂肪肝小鼠                       ethanol in vitro[J]. J Southwest Med Univ,2013,36(1):
              肝组织中过氧化物酶体增殖物活化受体 α 和甾醇调节                           35-38.
              元件结合蛋白1c及其调控关键靶分子的蛋白表达情况                       [14]  CHEN  L,YU  S,HONG  S  B,et  al.  Therapeutic  role  of
              [J]. 环境与健康杂志,2017,34(7):638-642.                    Artemether in the prevention of hepatic steatosis through
              DU Y C,XIAO M,YANG R,et al. Expression of peroxi‐   miR-34a-5p/PPARα pathway[J]. Drug Dev Res,2023,84
              some  proliferator-activated  receptor  α  and  sterol  regula‐  (2):156-171.
              tory element binding protein 1c and their key target mo-   [15]  TESCHKE  R.  Alcoholic  liver  disease:alcohol  metabo‐
              lecules in liver tissues of acute and chronic alcoholic fatty   lism,cascade  of  molecular  mechanisms,cellular  targets,
              liver mice[J]. J Environ Health,2017,34(7):638-642.  and clinical aspects[J]. Biomedicines,2018,6(4):106.
          [ 5 ]  石玉梦,杨佳璐,刘静,等. 两色金鸡菊中马里苷的肠道                  [16]  CHEN  X,ZHANG  Z,CUI  B,et  al.  Combination  of
              菌群代谢转化[J]. 现代食品科技,2023,39(11):68-77.                chronic  alcohol  consumption  and  high-salt  intake  elicits
              SHI Y M,YANG J L,LIU J,et al. Metabolic transforma‐  gut  microbial  alterations  and  liver  steatosis  in  mice[J].  J
              tion  of  marein  in  Coreopsis  tinctoria  Nutt. by  intestinal   Agric Food Chem,2020,68(6):1750-1759.
              flora[J]. Mod Food Sci Technol,2023,39(11):68-77.  [17]  KIM  H  G,HUANG  M  H,XIN Y,et  al. The  epigenetic
          [ 6 ]  GUO Y L,RAN Z,ZHANG Y W,et al. Marein amelio‐    regulator  SIRT6  protects  the  liver  from  alcohol-induced
              rates diabetic nephropathy by inhibiting renal sodium glu‐  tissue  injury  by  reducing  oxidative  stress  in  mice[J].  J
              cose  transporter  2  and  activating  the  AMPK  signaling   Hepatol,2019,71(5):960-969.
              pathway  in  db/db  mice  and  high  glucose-treated  HK-2   [18]  WANG  Y  P,NAKAJIMA  T,GONZALEZ  F  J,et  al.
              cells[J]. Biomed Pharmacother,2020,131:110684.      PPARs  as  metabolic  regulators  in  the  liver:lessons  from
          [ 7 ]  YAO M Y,ZHANG J,LI Z H,et al. Marein protects hu‐  liver-specific PPAR-null mice[J]. Int J Mol Sci,2020,21
              man nucleus pulposus cells against high glucose-induced   (6):2061.
              injury and extracellular matrix degradation at least partly   [19]  QIU Y Y,ZHANG J,ZENG F Y,et al. Roles of the per‐
              by inhibition of ROS/NF-κB pathway[J]. Int Immunophar‐  oxisome  proliferator-activated  receptors (PPARs)  in  the
              macol,2020,80:106126.                               pathogenesis of nonalcoholic fatty liver disease (NAFLD)
          [ 8 ]  张芳,祖力皮亚·阿布拉,克迪热亚·卡迪尔,等. 马里苷                      [J]. Pharmacol Res,2023,192:106786.
              对糖尿病小鼠肝脏和胰腺组织形态及自噬的影响[J]. 西                    [20]  BOUGARNE N,MYLKA V,RATMAN D,et al. Mecha‐
              部中医药,2024,37(2):4-8.                                nisms  underlying  the  functional  cooperation  between
              ZHANG  F,Zulipiya·Abula,Kedireya·Kadier,et  al.         PPARα and GRα to attenuate inflammatory responses[J].
              Influence of marein on histomorphology of liver and pan‐  Front Immunol,2019,10:1769.
              creas  and  autophagy  in  diabetic  mice[J].  West  J  Tradit   (收稿日期:2023-09-26  修回日期:2024-03-18)
              Chin Med,2024,37(2):4-8.                                                            (编辑:林 静)


          中国药房  2024年第35卷第9期                                                China Pharmacy  2024 Vol. 35  No. 9    · 1049 ·
   22   23   24   25   26   27   28   29   30   31   32